Category: News WellSyndicate content

Content tagged to appear in the middle column of the home page

BrainScope wins FDA clearance for Ahead 100 brain-injury scanner

November 21, 2014 by Val Kennedy

BrainScope wins U.S. regulatory clearance for its Ahead 100 device for detecting traumatic brain injury.

BrainScope wins FDA approval for Ahead 100 brain-injury scanner

BrainScope said it won 510(k) clearance from the FDA for its Ahead 100 device, designed to detect traumatic brain injury.

Covidien wins home-use CE Mark for Nellcor oxygen monitor

November 21, 2014 by Val Kennedy

Covidien says it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Covidien wins CE Mark for Nellcor oxygen monitor

Covidien (NYSE:COV) said it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

MassDevice.com +3 | The top 3 medtech stories for November 21, 2014

November 21, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Could cyber crooks really hack your pacemaker?

November 21, 2014 by MassDevice

Pacemakers get hacked on TV, but could it happen in real life?

Could cyber crooks really hack your pacemaker?

Kaiser Health News — Jay Radcliffe breaks into medical devices for a living, testing for vulnerabilities as a security researcher.

He's also a diabetic, and gives himself insulin injections instead of relying on an automated insulin pump, which he says could be hacked.

BD-CareFusion deal passes US anti-trust waiting period

November 21, 2014 by Mark Hollmer

Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.

BD-CareFusion deal passes US anti-trust waiting period

Startup Aortica raises $7m in Series A round, names Douthitt CEO

November 21, 2014 by Brad Perriello

Aortica raises $7 million in a Series A funding round for its customized abdominal aortic aneurysm device and names medtech veteran Tom Douthitt as its new CEO.

Aortica raises $7m in Series A round, names new CEO

Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.

Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp